Emmeline Lagunes-Cordoba summarises a cluster randomised controlled trial exploring the effectiveness of a low-intensity psychological intervention to reduce mental health stigma and improve help-seeking in the workplace.
[read the full story...]
In their debut Mental Elf blog, Martin Knapp and Gloria Wong summarise a systematic review of cost-of-illness studies, which explores the distribution of the costs between different mental health and neurodevelopmental conditions.
[read the full story...]
Chris Sampson summarises a review on the cost-effectiveness of mental health workplace interventions, which presents up-to-date evidence on the different things that employers can do to help those in their workforce affected by mental health problems or substance misuse.
[read the full story...]
Dafni Katsampa reflects on a new piece of qualitative research led by a 15 year old researcher, which focuses on teenagers’ experiences of the COVID-19 pandemic, and presents a set of recommendations for parents and families that cover mental wellbeing, the importance of routine, exercise and screen time.
[read the full story...]
Chris Sampson looks at a major new economic study into the return on investment of increased coverage for anxiety and depression treatment.
[read the full story...]
Our resident Elf Economist Chris Sampson summarises a recent report from Monitor (England’s health services regulator), which looks at how NHS providers can improve productivity in elective care.
[read the full story...]
Bipolar disorder is associated with high economic costs…or is it? Chris Sampson reports on a new systematic review, which highlights limitations in our understanding.
[read the full story...]
This is a summary of an evidence scan produced by The Health Foundation about lessons the NHS can learn from other countries about managing financial crisis.
[read the full story...]
Elf economist Chris Sampson reports on the economic evaluation of the CoBalT RCT, which finds that CBT is cost-effective for treatment resistant depression in primary care.
[read the full story...]
In addition to its impact on quality of life, panic disorder can have a number of costly consequences such as lost productivity – particularly if also associated with agoraphobia. Cost-effectiveness is therefore an important consideration in choosing the optimal treatment for panic disorder, which might improve value via the cost side of the equation. A recent [read the full story…]
